Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Draganfly Unveils New NDAA Compliant “FlexForce” Modular FPV System Following US Military Demonstrations & Training
-
Draganfly Unveils New NDAA Compliant “FlexForce” Modular FPV System Following US Military Demonstrations & Training
-
Crane NXT Completes Acquisition of OpSec Security
-
Tellabs Evolves Modern Enterprise Networking with In-Wall FlexSym ONT203W for fiber-based Passive Optical Networks
-
The Joint Corp. to Participate in Upcoming Investor Conferences
-
uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
-
Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
-
SES’s O3b mPOWER System Launches Service via Gilat’s SkyEdge IV Platform
-
INE Wins Four Cybersecurity Awards in 12th Annual Global InfoSec Awards at #RSAC 2024
-
Angus Gold Makes New High-Grade Gold Discovery West of Historic Dorset Resource Area, Intersects 7.0 g/t Au Over 12.4 Metres, including 21.7g/t Au Over 3.3 Metres
-
First Watch Restaurant Group, Inc. Reports Strong Q1 2024 Financial Results
-
Ascot Announces C$5.0 Million Non-Brokered Flow Through Private Placement
-
BioCryst to Present at Upcoming Investor Conferences
-
Meritage Homes Announces Pricing of Convertible Senior Notes
-
Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
-
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
West Red Lake Gold Intersects 21.33 g/t Au over 3.1m and 6.75 g/t Au over 9m at South Austin Zone – Madsen Mine
-
NioBay Confirms Phosphate in Historic Vior Drill Holes on Foothills Property
-
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Theriva™ Biologics Reports First Quarter 2024 Operational Highlights and Financial Results
-
Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference
-
Casino Time Elevates Social Gaming in Ontario with Launch of iGaming Website
-
GlobalFoundries Reports First Quarter 2024 Financial Results
-
Presenting on the Emerging Growth Conference 70 Day 1 on May 8 Register Now
-
Lightbend Adds Industry Veteran Dan Rosanova as Head Of Product
-
FibroGen to Participate in Upcoming Investor Conferences
-
Bioventus Reports First Quarter Financial Results
-
Think Power Solutions Continues to Excel as a Great Place to Work-Certified™ for Fourth Consecutive Year
-
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
-
Eli Electric Vehicles Opens Reservations for its Highly Anticipated Eli ZERO Micro-EV in the US
-
Snack’in For You’s Award Winning Veggie Puffs Debut at Sweets & Snacks Expo
-
Striim Appoints Neil Holloway as Senior Vice President of Partnerships to Accelerate Revenue Growth Through its Strategic Partnerships
-
Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024
-
Chicago Atlantic Real Estate Finance Announces First Quarter 2024 Financial Results
-
American Shared Hospital Services Announces First Quarter 2024 Earnings Conference Call
-
AIIR Launches Trusted Leadership Advisory Solution For C-Suite Executives
-
Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
-
Unlock AI High-Frequency Trading with Marine Moguls ERC-404 Airdrop
-
MAOCAT Presale Surpasses $300,000 with First-Ever Cat-Memecoin on Ethereum
-
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
-
Antelope Enterprise Announces Rescheduling of its Second Half and Fiscal Year End 2023 Earnings Conference Call
-
Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting
-
Blade Air Mobility Reports Financial Results for the First Quarter Ended March 31, 2024
-
InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th
-
Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102
-
Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
-
Red Cat Launches Robotics and Autonomous Systems Consortium to Bridge Critical UAS Technology Gaps for Warfighters
-
Airboss Announces Proposed Settlement of Class Action

